Maria Luisa Guerrera

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Steven P. Treon, Jorge J. Castillo, Alan P Skarbnik et al. · Blood · 2020 · 333 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Marzia Varettoni, Luca Arcaini, Silvia Zibellini et al. · Blood · 2013 · 329 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

Luca Arcaini, Silvia Zibellini, Emanuela Boveri et al. · Blood · 2011 · 164 citations · Full text

Veterinary Medicine, Genetics, Oncology +14

<i><scp>MYD</scp>88</i> wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival

Steven P. Treon, Joshua Gustine, Lian Xu et al. · British Journal of Haematology · 2017 · 105 citations · Full text

Medicine, Oncology, Pathology +17

<i>CXCR4</i> mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib

Jorge J. Castillo, Lian Xu, Joshua Gustine et al. · British Journal of Haematology · 2019 · 103 citations · Full text

Medicine, Molecular Genetics, Oncology +6